1,188 reports of this reaction
2.5% of all ESZOPICLONE reports
#6 most reported adverse reaction
FATIGUE is the #6 most commonly reported adverse reaction for ESZOPICLONE, manufactured by Waylis Therapeutics LLC. There are 1,188 FDA adverse event reports linking ESZOPICLONE to FATIGUE. This represents approximately 2.5% of all 47,350 adverse event reports for this drug.
Patients taking ESZOPICLONE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for ESZOPICLONE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for ESZOPICLONE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 1,188 FDA reports for ESZOPICLONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.5% of all adverse event reports for ESZOPICLONE, making it a notable side effect.
If you experience fatigue while taking ESZOPICLONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.